Document is current
Any future updates will be listed below
-
Authors
Tominaga, Ryutaro
Umino, Kento
Honda, Seina
Yokoyama, Daizo
Noguchi, Atsuto
Furuki, Shuka
Koyama, Shunsuke
Murahashi, Rui
Nakashima, Hirotomo
Hyodo, Kazuki
Kawaguchi, Shin-ichiro
Toda, Yumiko
Minakata, Daisuke
Ashizawa, Masahiro
Yamamoto, Chihiro
Hatano, Kaoru
Sato, Kazuya
Ohmine, Ken
Fujiwara, Shin-ichiro
Kanda, Yoshinobu https://orcid.org/0000-0002-4866-9307
- License Information
-
More Information
Article History
Received: 4 October 2024
Revised: 17 January 2025
Accepted: 19 January 2025
First Online: 29 January 2025
Declarations
:
: D. Minakata has received payments for lectures from Bristol Myers Squibb and Janssen Pharmaceutical K.K. S. Fujiwara has received payments for lectures from Bristol Myers Squibb. K. Ohmine has received research grants from Takara Biomedical Inc. Y. Kanda has received payment for lectures from Pfizer Japan Inc., Sumitomo Pharma Co., Ltd., Novartis Pharma K.K., Sanofi K.K., CHUGAI PHARMACEUTICAL CO., LTD., SymBio Pharmaceuticals Limited, Bristol Myers Squibb, Janssen Pharmaceutical K.K, ASAHI KASEI PHARMA CORPORATION, MSD K.K., Astellas Pharma Inc. and Kyowa Kirin Co., Ltd. Y. Kanda has received research grants from Celgene Corporation, Sumitomo Pharma Co., Ltd., Kyowa Kirin Co., Ltd., CHUGAI PHARMACEUTICAL CO., LTD., and Eisai Co., Ltd. These are not related to the current study. Y. Kanda is involved in the editing of International Journal of Hematology as an associate editor. The other authors have no conflicts of interest to declare.
